KR20130030049A - The health food composition for regulating weight and increasing the satiety - Google Patents
The health food composition for regulating weight and increasing the satiety Download PDFInfo
- Publication number
- KR20130030049A KR20130030049A KR1020110093557A KR20110093557A KR20130030049A KR 20130030049 A KR20130030049 A KR 20130030049A KR 1020110093557 A KR1020110093557 A KR 1020110093557A KR 20110093557 A KR20110093557 A KR 20110093557A KR 20130030049 A KR20130030049 A KR 20130030049A
- Authority
- KR
- South Korea
- Prior art keywords
- brown rice
- food composition
- powder
- germinated brown
- composition
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 30
- 235000013402 health food Nutrition 0.000 title abstract description 4
- 230000036186 satiety Effects 0.000 title description 9
- 235000019627 satiety Nutrition 0.000 title description 9
- 230000001965 increasing effect Effects 0.000 title description 5
- 230000001105 regulatory effect Effects 0.000 title 1
- 235000013305 food Nutrition 0.000 claims abstract description 27
- 235000021329 brown rice Nutrition 0.000 claims abstract description 24
- 239000002994 raw material Substances 0.000 claims abstract description 24
- 239000000843 powder Substances 0.000 claims abstract description 18
- 235000011511 Diospyros Nutrition 0.000 claims abstract description 17
- 238000001035 drying Methods 0.000 claims abstract description 15
- 244000236655 Diospyros kaki Species 0.000 claims abstract description 13
- 241000512259 Ascophyllum nodosum Species 0.000 claims abstract description 12
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims abstract description 12
- 235000013312 flour Nutrition 0.000 claims abstract description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 11
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims abstract description 10
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims abstract description 10
- 229920002472 Starch Polymers 0.000 claims abstract description 10
- 244000269722 Thea sinensis Species 0.000 claims abstract description 10
- 235000019698 starch Nutrition 0.000 claims abstract description 10
- 239000008107 starch Substances 0.000 claims abstract description 10
- 235000009569 green tea Nutrition 0.000 claims abstract description 9
- 235000010356 sorbitol Nutrition 0.000 claims abstract description 9
- 238000004898 kneading Methods 0.000 claims abstract description 8
- 239000000600 sorbitol Substances 0.000 claims abstract description 8
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims abstract description 7
- 235000013355 food flavoring agent Nutrition 0.000 claims abstract description 7
- 239000000787 lecithin Substances 0.000 claims abstract description 7
- 235000010445 lecithin Nutrition 0.000 claims abstract description 7
- 229940067606 lecithin Drugs 0.000 claims abstract description 7
- 239000006187 pill Substances 0.000 claims abstract description 7
- 238000004519 manufacturing process Methods 0.000 claims abstract description 6
- 235000005152 nicotinamide Nutrition 0.000 claims abstract description 6
- 239000011570 nicotinamide Substances 0.000 claims abstract description 6
- -1 polydentrose Substances 0.000 claims abstract description 6
- 238000005406 washing Methods 0.000 claims abstract description 6
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims abstract description 5
- 240000005979 Hordeum vulgare Species 0.000 claims abstract description 5
- 235000007340 Hordeum vulgare Nutrition 0.000 claims abstract description 5
- 239000008213 purified water Substances 0.000 claims abstract description 5
- 235000019192 riboflavin Nutrition 0.000 claims abstract description 5
- 229960002477 riboflavin Drugs 0.000 claims abstract description 5
- 239000002151 riboflavin Substances 0.000 claims abstract description 5
- 239000008371 vanilla flavor Substances 0.000 claims abstract description 5
- 230000001954 sterilising effect Effects 0.000 claims abstract description 4
- 238000004659 sterilization and disinfection Methods 0.000 claims abstract description 3
- 235000010469 Glycine max Nutrition 0.000 claims description 18
- 241000234435 Lilium Species 0.000 claims description 16
- 241001474374 Blennius Species 0.000 claims description 15
- 244000068988 Glycine max Species 0.000 claims description 15
- 238000000855 fermentation Methods 0.000 claims description 12
- 230000004151 fermentation Effects 0.000 claims description 12
- DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 10
- 239000004480 active ingredient Substances 0.000 claims description 8
- 235000003130 Arctium lappa Nutrition 0.000 claims description 5
- 235000008078 Arctium minus Nutrition 0.000 claims description 5
- 229920001100 Polydextrose Polymers 0.000 claims description 5
- 239000001259 polydextrose Substances 0.000 claims description 5
- 235000013856 polydextrose Nutrition 0.000 claims description 5
- 229940035035 polydextrose Drugs 0.000 claims description 5
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims description 4
- 235000013527 bean curd Nutrition 0.000 claims description 3
- 239000008369 fruit flavor Substances 0.000 claims description 3
- 229940011671 vitamin b6 Drugs 0.000 claims description 3
- 240000005528 Arctium lappa Species 0.000 claims 1
- 244000000231 Sesamum indicum Species 0.000 claims 1
- 235000003434 Sesamum indicum Nutrition 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- 235000008160 pyridoxine Nutrition 0.000 claims 1
- 239000011677 pyridoxine Substances 0.000 claims 1
- 235000012054 meals Nutrition 0.000 abstract description 14
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 abstract description 8
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 abstract description 6
- 239000011764 pyridoxine hydrochloride Substances 0.000 abstract description 6
- 229960004172 pyridoxine hydrochloride Drugs 0.000 abstract description 6
- 244000046052 Phaseolus vulgaris Species 0.000 abstract description 4
- 235000010627 Phaseolus vulgaris Nutrition 0.000 abstract description 4
- 238000004260 weight control Methods 0.000 abstract description 3
- 239000000654 additive Substances 0.000 abstract description 2
- 235000013399 edible fruits Nutrition 0.000 abstract description 2
- 244000237330 gutta percha tree Species 0.000 abstract description 2
- 238000010298 pulverizing process Methods 0.000 abstract description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 abstract 1
- 229930064664 L-arginine Natural products 0.000 abstract 1
- 235000014852 L-arginine Nutrition 0.000 abstract 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 abstract 1
- 244000067505 Xanthium strumarium Species 0.000 abstract 1
- 230000000996 additive effect Effects 0.000 abstract 1
- 239000002304 perfume Substances 0.000 abstract 1
- 239000004332 silver Substances 0.000 abstract 1
- 229910052709 silver Inorganic materials 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 17
- 108090000790 Enzymes Proteins 0.000 description 14
- 102000004190 Enzymes Human genes 0.000 description 14
- 229940088598 enzyme Drugs 0.000 description 14
- 239000003925 fat Substances 0.000 description 14
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 12
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 11
- 239000004615 ingredient Substances 0.000 description 10
- 208000008589 Obesity Diseases 0.000 description 9
- 230000004060 metabolic process Effects 0.000 description 9
- 235000020824 obesity Nutrition 0.000 description 9
- 229940088594 vitamin Drugs 0.000 description 9
- 229930003231 vitamin Natural products 0.000 description 9
- 235000013343 vitamin Nutrition 0.000 description 9
- 239000011782 vitamin Substances 0.000 description 9
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 8
- 230000009471 action Effects 0.000 description 8
- 235000001014 amino acid Nutrition 0.000 description 8
- 239000003814 drug Substances 0.000 description 8
- 230000006870 function Effects 0.000 description 8
- 229960002920 sorbitol Drugs 0.000 description 8
- 238000010521 absorption reaction Methods 0.000 description 7
- 210000000577 adipose tissue Anatomy 0.000 description 7
- 150000001413 amino acids Chemical class 0.000 description 7
- 229940079593 drug Drugs 0.000 description 7
- 230000004580 weight loss Effects 0.000 description 7
- 235000019789 appetite Nutrition 0.000 description 6
- 230000036528 appetite Effects 0.000 description 6
- 235000012000 cholesterol Nutrition 0.000 description 6
- 229910052500 inorganic mineral Inorganic materials 0.000 description 6
- 239000011707 mineral Substances 0.000 description 6
- 235000015097 nutrients Nutrition 0.000 description 6
- 206010010774 Constipation Diseases 0.000 description 5
- 235000010443 alginic acid Nutrition 0.000 description 5
- 229920000615 alginic acid Polymers 0.000 description 5
- 230000003078 antioxidant effect Effects 0.000 description 5
- 235000005911 diet Nutrition 0.000 description 5
- 230000037213 diet Effects 0.000 description 5
- 235000010755 mineral Nutrition 0.000 description 5
- 235000018102 proteins Nutrition 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical group [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 4
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 4
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 4
- 229930003268 Vitamin C Natural products 0.000 description 4
- 238000009825 accumulation Methods 0.000 description 4
- 239000000783 alginic acid Substances 0.000 description 4
- 229960001126 alginic acid Drugs 0.000 description 4
- 239000011575 calcium Substances 0.000 description 4
- 229910052791 calcium Inorganic materials 0.000 description 4
- 235000001465 calcium Nutrition 0.000 description 4
- 150000001720 carbohydrates Chemical class 0.000 description 4
- 235000014633 carbohydrates Nutrition 0.000 description 4
- 239000000919 ceramic Substances 0.000 description 4
- 206010061428 decreased appetite Diseases 0.000 description 4
- 235000013325 dietary fiber Nutrition 0.000 description 4
- 239000011630 iodine Substances 0.000 description 4
- 229910052740 iodine Inorganic materials 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 239000011591 potassium Substances 0.000 description 4
- 229910052700 potassium Inorganic materials 0.000 description 4
- 235000007686 potassium Nutrition 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 235000019154 vitamin C Nutrition 0.000 description 4
- 239000011718 vitamin C Substances 0.000 description 4
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 3
- 244000055850 Diospyros virginiana Species 0.000 description 3
- 241000287828 Gallus gallus Species 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 3
- 206010039897 Sedation Diseases 0.000 description 3
- 150000004781 alginic acids Chemical class 0.000 description 3
- 230000001093 anti-cancer Effects 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 3
- 235000005487 catechin Nutrition 0.000 description 3
- 229930002875 chlorophyll Natural products 0.000 description 3
- 235000019804 chlorophyll Nutrition 0.000 description 3
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 206010016256 fatigue Diseases 0.000 description 3
- 230000035784 germination Effects 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 239000011777 magnesium Substances 0.000 description 3
- 229910052749 magnesium Inorganic materials 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 230000003880 negative regulation of appetite Effects 0.000 description 3
- 150000008442 polyphenolic compounds Chemical class 0.000 description 3
- 235000013824 polyphenols Nutrition 0.000 description 3
- 230000036280 sedation Effects 0.000 description 3
- 239000005495 thyroid hormone Substances 0.000 description 3
- 229940036555 thyroid hormone Drugs 0.000 description 3
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 2
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 description 2
- AUNGANRZJHBGPY-MBNYWOFBSA-N 7,8-dimethyl-10-[(2R,3R,4S)-2,3,4,5-tetrahydroxypentyl]benzo[g]pteridine-2,4-dione Chemical compound OC[C@H](O)[C@H](O)[C@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-MBNYWOFBSA-N 0.000 description 2
- 206010000060 Abdominal distension Diseases 0.000 description 2
- 241000208843 Arctium Species 0.000 description 2
- 244000294263 Arctium minus Species 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 2
- 208000008035 Back Pain Diseases 0.000 description 2
- 206010009944 Colon cancer Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 208000008930 Low Back Pain Diseases 0.000 description 2
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- AUYYCJSJGJYCDS-LBPRGKRZSA-N Thyrolar Chemical class IC1=CC(C[C@H](N)C(O)=O)=CC(I)=C1OC1=CC=C(O)C(I)=C1 AUYYCJSJGJYCDS-LBPRGKRZSA-N 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 239000002830 appetite depressant Substances 0.000 description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
- 235000009697 arginine Nutrition 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- 230000003385 bacteriostatic effect Effects 0.000 description 2
- 230000000975 bioactive effect Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 230000004641 brain development Effects 0.000 description 2
- 210000000748 cardiovascular system Anatomy 0.000 description 2
- 235000005473 carotenes Nutrition 0.000 description 2
- 150000001746 carotenes Chemical class 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 229950001002 cianidanol Drugs 0.000 description 2
- 208000029742 colonic neoplasm Diseases 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 210000002249 digestive system Anatomy 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 229930182486 flavonoid glycoside Natural products 0.000 description 2
- 150000007955 flavonoid glycosides Chemical class 0.000 description 2
- 210000004051 gastric juice Anatomy 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 229910001385 heavy metal Inorganic materials 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 230000004130 lipolysis Effects 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- AHLBNYSZXLDEJQ-FWEHEUNISA-N orlistat Chemical compound CCCCCCCCCCC[C@H](OC(=O)[C@H](CC(C)C)NC=O)C[C@@H]1OC(=O)[C@H]1CCCCCC AHLBNYSZXLDEJQ-FWEHEUNISA-N 0.000 description 2
- 229960001243 orlistat Drugs 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 230000035935 pregnancy Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- UNAANXDKBXWMLN-UHFFFAOYSA-N sibutramine Chemical compound C=1C=C(Cl)C=CC=1C1(C(N(C)C)CC(C)C)CCC1 UNAANXDKBXWMLN-UHFFFAOYSA-N 0.000 description 2
- 229960004425 sibutramine Drugs 0.000 description 2
- 229940032147 starch Drugs 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 235000018553 tannin Nutrition 0.000 description 2
- 239000001648 tannin Substances 0.000 description 2
- 229920001864 tannin Polymers 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 108700012359 toxins Proteins 0.000 description 2
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 2
- 235000019156 vitamin B Nutrition 0.000 description 2
- 239000011720 vitamin B Substances 0.000 description 2
- 235000010374 vitamin B1 Nutrition 0.000 description 2
- 239000011691 vitamin B1 Substances 0.000 description 2
- 235000019158 vitamin B6 Nutrition 0.000 description 2
- 239000011726 vitamin B6 Substances 0.000 description 2
- DBTMGCOVALSLOR-DEVYUCJPSA-N (2s,3r,4s,5r,6r)-4-[(2s,3r,4s,5r,6r)-3,5-dihydroxy-6-(hydroxymethyl)-4-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](CO)O[C@H](O)[C@@H]2O)O)O[C@H](CO)[C@H]1O DBTMGCOVALSLOR-DEVYUCJPSA-N 0.000 description 1
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 description 1
- LQIAZOCLNBBZQK-UHFFFAOYSA-N 1-(1,2-Diphosphanylethyl)pyrrolidin-2-one Chemical compound PCC(P)N1CCCC1=O LQIAZOCLNBBZQK-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- XUIIKFGFIJCVMT-GFCCVEGCSA-N D-thyroxine Chemical compound IC1=CC(C[C@@H](N)C(O)=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-GFCCVEGCSA-N 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 241000723267 Diospyros Species 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 229920002581 Glucomannan Polymers 0.000 description 1
- 102000018997 Growth Hormone Human genes 0.000 description 1
- 108010051696 Growth Hormone Proteins 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- 229920001543 Laminarin Polymers 0.000 description 1
- 239000005717 Laminarin Substances 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 201000001880 Sexual dysfunction Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 229930003270 Vitamin B Chemical group 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- UGXQOOQUZRUVSS-ZZXKWVIFSA-N [5-[3,5-dihydroxy-2-(1,3,4-trihydroxy-5-oxopentan-2-yl)oxyoxan-4-yl]oxy-3,4-dihydroxyoxolan-2-yl]methyl (e)-3-(4-hydroxyphenyl)prop-2-enoate Chemical compound OC1C(OC(CO)C(O)C(O)C=O)OCC(O)C1OC1C(O)C(O)C(COC(=O)\C=C\C=2C=CC(O)=CC=2)O1 UGXQOOQUZRUVSS-ZZXKWVIFSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000003579 anti-obesity Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229920000617 arabinoxylan Polymers 0.000 description 1
- 229960003121 arginine Drugs 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 208000024330 bloating Diseases 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 230000036995 brain health Effects 0.000 description 1
- 229960005069 calcium Drugs 0.000 description 1
- 229940069978 calcium supplement Drugs 0.000 description 1
- 235000019577 caloric intake Nutrition 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 229960004203 carnitine Drugs 0.000 description 1
- 150000001765 catechin Chemical class 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000013522 chelant Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000013330 chicken meat Nutrition 0.000 description 1
- 201000001883 cholelithiasis Diseases 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- 235000013495 cobalt Nutrition 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 231100000517 death Toxicity 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 230000001278 effect on cholesterol Effects 0.000 description 1
- 210000002257 embryonic structure Anatomy 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 235000021321 essential mineral Nutrition 0.000 description 1
- 235000020774 essential nutrients Nutrition 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 235000019000 fluorine Nutrition 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 235000019525 fullness Nutrition 0.000 description 1
- 208000001130 gallstones Diseases 0.000 description 1
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 1
- FODTZLFLDFKIQH-FSVGXZBPSA-N gamma-Oryzanol (TN) Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)O[C@@H]2C([C@@H]3CC[C@H]4[C@]5(C)CC[C@@H]([C@@]5(C)CC[C@@]54C[C@@]53CC2)[C@H](C)CCC=C(C)C)(C)C)=C1 FODTZLFLDFKIQH-FSVGXZBPSA-N 0.000 description 1
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 1
- 230000005176 gastrointestinal motility Effects 0.000 description 1
- 229940046240 glucomannan Drugs 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000003163 gonadal steroid hormone Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000000122 growth hormone Substances 0.000 description 1
- 230000009036 growth inhibition Effects 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 208000024963 hair loss Diseases 0.000 description 1
- 230000003676 hair loss Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 235000004280 healthy diet Nutrition 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000030214 innervation Effects 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical group O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- 150000002496 iodine Chemical class 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000002366 lipolytic effect Effects 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 235000021097 low calorie intake Nutrition 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000006371 metabolic abnormality Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 235000021590 normal diet Nutrition 0.000 description 1
- 235000021049 nutrient content Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 210000004798 organs belonging to the digestive system Anatomy 0.000 description 1
- 229940124595 oriental medicine Drugs 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 238000011056 performance test Methods 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 235000013594 poultry meat Nutrition 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 239000011265 semifinished product Substances 0.000 description 1
- 231100000872 sexual dysfunction Toxicity 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 235000014214 soft drink Nutrition 0.000 description 1
- 235000019710 soybean protein Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 230000007103 stamina Effects 0.000 description 1
- 208000001162 steatorrhea Diseases 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 229940034208 thyroxine Drugs 0.000 description 1
- XUIIKFGFIJCVMT-UHFFFAOYSA-N thyroxine-binding globulin Natural products IC1=CC(CC([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-UHFFFAOYSA-N 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 235000021119 whey protein Nutrition 0.000 description 1
- 150000003735 xanthophylls Chemical class 0.000 description 1
- 235000008210 xanthophylls Nutrition 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
- A23L33/24—Cellulose or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L11/00—Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
- A23L11/05—Mashed or comminuted pulses or legumes; Products made therefrom
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
- A23L33/29—Mineral substances, e.g. mineral oils or clays
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
- A23L7/152—Cereal germ products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/20—Agglomerating; Granulating; Tabletting
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Health & Medical Sciences (AREA)
- Mycology (AREA)
- Botany (AREA)
- Agronomy & Crop Science (AREA)
- Dispersion Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
본 발명은 발아현미, 발아콩, 미역, 백합 및 감잎을 유효성분으로 포함하는 식품조성물 및 그 제조방법에 관한 것이다.
The present invention relates to a food composition comprising germinated brown rice, germinated soybean, seaweed, lily and persimmon leaf as an active ingredient and a method for producing the same.
본 발명은 포만감과 체지방 대사를 증가시키는 체중조절용 건강식품 조성물에 관한 것으로서 보다 상세하게는 본 발명은 발아현미, 발아콩, 미역, 백합 및 감잎을 유효성분으로 포함하는 식품조성물에 관한 것이다.The present invention relates to a health food composition for weight control to increase satiety and body fat metabolism, and more particularly, to a food composition comprising germinated brown rice, germinated soybean, seaweed, lily and persimmon leaf as active ingredients.
비만은 에너지 섭취와 소비가 균형을 이루지 못하여 에너지가 과다 축적되어 체지방이 비정상적으로 많아지며 대사 이상이 발생하는 상태를 말한다. 비만으로 인해 당뇨병 및 고지혈증이 생길 가능성이 높아지고, 성기능 장애, 관절염, 심혈관계 질환의 발병 위험이 커진다. 담석증이 생길 수 있으며 일부의 경우 암의 발생과도 연관이 있다. 비만을 예방하기 위한 방법으로는 생활 습관을 개선하여 식사량을 줄이고 운동량을 증가시켜야 한다. 그러나 현대사회에서는 업무량 등으로 인하여 운동을 하기가 어렵고 대부분 외부에서 식사를 해결하기 때문에 칼로리를 조절하기 어렵다. 또한, 체중을 줄이기 위하여 음식의 섭취량을 줄이는 경우 영양분의 불균형으로 건강에 이상을 가져올 수 있다. 비만을 치료하기 위하여 약물을 통해 비만을 치료하기도 한다. 비만 치료에 사용되는 약물의 종류는 크게 식욕억제제와 지방의 흡수를 저해하는 약으로 나눌 수 있고, 장기간 사용이 허가되어온 약물은 시부트라민(sibutramine)과 오르리스타트(orlistat) 두 가지가 있다.Obesity is a condition in which energy intake and consumption are not balanced, resulting in excessive accumulation of energy resulting in abnormally high body fat and metabolic abnormalities. Obesity increases the likelihood of developing diabetes and hyperlipidemia, and increases the risk of developing sexual dysfunction, arthritis, and cardiovascular disease. Gallstones can develop and in some cases are also linked to cancer. As a way to prevent obesity, you should improve your lifestyle to reduce diet and increase exercise. However, in modern society, it is difficult to exercise due to workload, and it is difficult to control calories because most of them solve meals outside. In addition, reducing the intake of food in order to lose weight can bring health problems due to the imbalance of nutrients. In order to treat obesity, obesity can be treated through drugs. There are two types of drugs used to treat obesity, which are appetite suppressants and drugs that inhibit the absorption of fat. There are two drugs that have been approved for long-term use: sibutramine and orlistat.
시부트라민은 식욕억제제의 일종으로 1년 동안 복용할 경우 평균적으로 약 5~9%의 체중을 줄여준다. 그러나 약으로 인해 두통, 구갈(심한 갈증), 불면증 및 변비 등의 부작용이 발생할 수 있고, 심혈관계의 부작용이 나타날 수 있으며, 제품의 시판 후 임상평가에서 실제로 심혈관계의 심각한 부작용이 나타나고, 심장 부작용으로 인한 사망사고가 다수 발생하여 현재 시판이 금지되어 있다.Sibutramine is a form of appetite suppressant that, when taken for a year, loses about 5-9% of its weight on average. However, the drug may cause side effects such as headache, thirst (severe thirst), insomnia and constipation, side effects of the cardiovascular system, and serious side effects of the cardiovascular system in the post-marketing clinical evaluation of the product. The company has been banned due to the high number of deaths.
오르리스타트는 지방분해효소의 억제제로 체내에서 지방이 소화되지 못하도록 하는 약이다. 따라서 섭취한 지방의 약 30%는 소화 및 흡수되지 않고 그대로 몸 밖으로 배출된다. 부작용으로 대변이 자주 마렵거나 지방변 등이 나타날 수 있고 지방 흡수율의 감소로 인해 장에서의 지용성비타민의 흡수율도 떨어질 수 있다는 문제점이 있다. Orlistat is a drug that inhibits fat digestion in the body by inhibiting lipolytic enzymes. Therefore, about 30% of the ingested fat is not digested and absorbed and is released out of the body. As a side effect, stool may be frequently quenched or fatty stool may appear, and the absorption rate of fat-soluble vitamins in the intestine may decrease due to a decrease in fat absorption rate.
또한, 대한민국 공개특허 10-2008-0049330에서는 유청단백, 분리대두단백 및 글루코만난을 이용한 포만감을 주는 식품조성물을 개시하고 있으며, 상기 조성물의 경우 식사대용으로 저칼로리 고단백을 가지는 식품조성물로서 매우 유용하나 식욕억제, 지방분해 등의 종합적인 비만억제 효과를 제공하고 있지는 못하다는 문제점이 있다.
In addition, the Republic of Korea Patent Publication No. 10-2008-0049330 discloses a food composition that gives a feeling of satiety using whey protein, soybean protein and glucomannan, the composition is very useful as a food composition having a low-calorie high protein as a meal replacement There is a problem that it does not provide a comprehensive anti-obesity effect such as fat decomposition.
본 발명자는 식욕억제 및 체지방 분해효능을 가지면서도 섭취시 포만감을 주는 식품조성물을 개발하고자 연구하던 중 발아현미, 발아콩, 미역, 백합 및 감잎을 유효성분으로 포함하는 조성물을 이용하는 경우 이러한 효과를 달성할 수 있다는 것을 규명함으로써 본 발명을 완성하게 되었다.The present inventors achieve this effect when using a composition containing germinated brown rice, germinated soybean, seaweed, lily and persimmon leaf as an active ingredient while researching to develop a food composition having appetite suppression and body fat degrading effect and feeling full when ingested. The present invention has been completed by identifying that it can be done.
따라서 본 발명의 목적은 발아현미, 발아콩, 미역, 백합 및 감잎을 유효성분으로 포함하는 식품조성물을 제공하는데 있다.Accordingly, an object of the present invention is to provide a food composition comprising germinated brown rice, germinated soybean, seaweed, lily and persimmon leaf as an active ingredient.
본 발명의 다른 목적은 발아콩, 다시마, 미역, 두충, 녹차, 백합, 감잎, 우엉 계내금을 세척하고 건조기에서 70 내지 90 ℃에서 건조하는 세척 및 건조단계, 원료를 분쇄기에 투여하여 분말 형태로 분쇄하는 단계 및 분말 형태로 분쇄된 원료에 정제수를 투여하여 반죽하고 발효하는 단계를 포함하는 식품조성물의 제조방법을 제공하는데 있다.
Another object of the present invention is to wash germinated soybeans, kelp, seaweed, tofu, green tea, lily, persimmon leaf, burdock sediment and to dry at 70 to 90 ℃ in a dryer, the raw material is administered to the grinder in powder form It provides a method for producing a food composition comprising the step of pulverizing and kneading by administering purified water to the raw material pulverized in the form of powder.
본 발명의 일 양태에 따르면 발아현미, 발아콩, 미역, 백합 및 감잎을 유효성분으로 포함하는 식품조성물을 제공한다.According to one aspect of the present invention provides a food composition comprising germinated brown rice, germinated soybean, seaweed, lily and persimmon leaf as an active ingredient.
본 발명에서 사용되는 “발아현미”는 씨눈으로부터 싹이 튼 상태, 즉 발아 상태에 있는 현미를 의미한다. 싹이 트는 시기에는 새 생명에게 영양분을 공급하기 위해 종자가 가지고 있는 영양 물질을 분해할 각종 효소가 증대되고, 전에 없던 새로운 영양분도 생성된다. 곡류를 발아시키면 비타민과 미네랄, 아미노산, 감마오리자놀, 아라비녹시란, 엽록소 등이 생겨 우리 몸의 신진대사가 원활하게 이뤄지도록 도와준다. 그중에서 감마오리자놀은 뇌의 혈액순환을 활발하게 하여 산소 공급량을 증가시키고 뇌세포 대사 기능을 높여준다. 또한 발아 도중에는 곡물의 피틴질을 분해하는 효소가 생성되어 피틴질이노시톨로 변한다. 이것은 비타민 B군의 하나로 지방 분해와 연소를 촉진해 비만과 동맥경화, 지방간 치료에도 도움이 된다.현미의 종피와 배아에 분포되어 있는 아라비노자일란이라는 물질도 싹이 트는 시기에 증가되는데, 이 물질은 물을 흡착하고 점성을 나타내기 때문에 적은 양을 먹어도 포만감을 준다. As used herein, "germinated brown rice" refers to brown rice in a sprouted state, that is, in a germinated state. At the time of sprouting, various enzymes are added to break down the nutrients of seeds to nourish new life, and new nutrients are produced that were not there before. When you germinate grains, vitamins, minerals, amino acids, gamma-olizanol, arabinoxyran, and chlorophyll can help your body's metabolism work smoothly. Among them, gamma-oryzanol stimulates blood circulation in the brain, increasing oxygen supply and enhancing brain cell metabolism. During germination, enzymes are also produced that break down the phytotin of the grains, which then turn into phytinyl inositol. It is a group of B vitamins that promotes lipolysis and burning to help treat obesity, arteriosclerosis, and fatty liver.Arabinoxylan, a substance found in brown rice hulls and embryos, increases during sprouting. Because it adsorbs water and exhibits viscosity, even small doses give fullness.
발아현미는 또한 칼슘과 비타민B군의 함유량이 현미보다 높고 자정작용이 커서 일반적인 건강효과뿐 아니라 체질개선에도 좋은 효과를 얻을 수 있다. 특히 현미가 발아하는 과정에서 비타민· 아미노산· 효소· SOD(superoxide dismutase) 등 몸에 유용한 성분들이 생성되며, 몸의 자연치유력을 높이고 성인병을 예방하며 몸의 독소를 씻어내는 해독작용을 한다.Germinated brown rice also has a higher content of calcium and vitamin B groups than brown rice and has a great self-cleaning effect, which can be used to improve not only general health but also constitution. In particular, during the germination of brown rice, useful ingredients such as vitamins, amino acids, enzymes, and superoxide dismutases (SODs) are produced, which enhances the body's natural healing power, prevents adult diseases, and detoxifies the body's toxins.
본 발명에서 사용되는 용어 “발아콩”은 싹이 튼 상태의 콩을 의미하며, 콩이 발아되는 과정에서 단백질은 아미노산으로, 지방은 필수 지방산으로 변하며 미네랄, 효소, 비타민 등이 증가한다. 또한 식이섬유와 아미노산의 일종인 아스파라긴산 등의 영양소 함량도 증가한다. As used herein, the term “germinated bean” refers to a sprouted soybean. In the process of germinating soy, protein is converted into an amino acid, fat is converted into an essential fatty acid, and minerals, enzymes, vitamins, and the like are increased. It also increases nutrient content such as dietary fiber and aspartic acid, a type of amino acid.
(주)두산 식품연구소에 따르면 발아 과정이 여성들에게 좋은 성분으로 알려진 이소플라본 함량을 크게 증가시킨다는 사실을 확인했으며, 체내 생리 활성 물질과 두뇌 건강에 좋은 GABA 함량도 크게 증가되었다고 한다. According to the Doosan Food Research Institute, the germination process significantly increased the isoflavone content, which is known to be a good ingredient for women, and the GABA content, which is good for the body's bioactive substances and brain health, was also greatly increased.
발아 콩에는 단백질과 지방질이 많이 함유되어 있으며, 풍부한 섬유질을 가지고 비타민 B1, B2, 아스코르빈산(ascorbic acid, 비타민 C)의 함유량도 높다.Germinated soybeans are high in protein and fat, rich in fiber and high in vitamins B1, B2 and ascorbic acid ( vitamin C).
다시마는 카로틴류· 크산토필류· 엽록소 등의 여러 가지 색소 외에 탄소동화작용으로 만들어지는 마니트· 라미나린 등의 탄수화물과 세포벽의 성분인 알긴산이 많이 함유되어 있고, 요오드· 비타민 B2· 글루타민산 등의 아미노산이 함유되어 있다. 다시마에 포함된 알긴산은 변비예방 및 개선 및 대장암을 예방하며, 중금속과 지방 등의 유해한 물질의 흡수를 억제하고 대장의 운동을 도와 체내의 쌓인 독성물질을 몸 밖으로 배출시켜 피를 맑게 해주며 콜레스테롤의 수치를 낮춰 또는 정상으로 유지 시켜준다. 다시마는 저칼로리(100g 18kcal) 식품이며 미네랄이 풍부하게 함유되어 있어서 다이어트에 좋은 식품으로 알려져 있다. 다시마에 풍부하게 함유된 요오드는 신진대사를 도와주고 갑상선 호르몬을 만들어 주며 뇌 발달에 반드시 필요한 영양소이다. 이 요오드 성분이 부족해지게 되면 갑상선 호르몬이 원활하지 못하게 되어 만성피로가 올수 있고 유아의 뇌 발달을 저하시키며 집중력 결핍을 불러 올수 있다. 때문에 다시마의 요오드 성분은 섭취하면 체력이 회복되고 권태감 해소 및 피로회복에 효과를 볼 수 있다. 다시마에는 칼륨과 마그네슘이 함유되어 있으며, 칼륨은 우리 몸에 저장되어 있는 염분을 체외로 배출시키고 마그네슘은 혈관을 이완시키는 효능 때문에 혈압을 떨어뜨려 주거나 조절하는 작용을 한다. 또한 다시마에는 칼슘이 함유되어 있어 뼈와 이를 튼튼하게 만들어 주고 골다공증 예방에 효과가 있다. Kelp contains carbohydrates such as carnitine, xanthophylls, and chlorophyll, as well as carbohydrates, such as mannite and laminarin, which are made by carbon assimilation, and alginic acid, which is a component of cell walls. Contains amino acids Alginic acid contained in kelp prevents and improves constipation and prevents colon cancer, inhibits the absorption of harmful substances such as heavy metals and fats, and helps the movement of the large intestine to clear the blood by releasing accumulated toxic substances out of the body and cholesterol Lower the value of or keep it normal. Kelp is a low-calorie (100g 18kcal) food and rich in minerals, it is known as a good food for diet. Rich in kelp, iodine is an essential nutrient for metabolism, thyroid hormone production, and brain development. Lack of this iodine component can cause thyroid hormones to be impaired, leading to chronic fatigue, poor brain development in infants, and lack of concentration. Therefore, the iodine component of kelp recovers stamina and can help reduce fatigue and relieve fatigue. Kelp contains potassium and magnesium, and potassium releases salt stored in our body to the outside, and magnesium acts to reduce or regulate blood pressure due to the effect of relaxing blood vessels. In addition, kelp contains calcium, which makes bones and teeth strong and prevents osteoporosis.
본 발명에서 이용되는 미역은 알긴산과 요오드, 칼슘, 비타민 B1, B2, B12, C, 아미노산, 칼륨, 코발트, 불소, 카로틴, 단백질 등이 풍부하여 신진대사를 활발하게 하고, 변비. 비만 예방, 철분. 칼슘 보충에 탁월하다. Seaweed used in the present invention is rich in alginic acid and iodine, calcium, vitamins B1, B2, B12, C, amino acids, potassium, cobalt, fluorine, carotene, protein, etc., active metabolism, constipation. Obesity prevention, iron. Excellent for calcium supplements
다시마와 미역에 포함되어 있는 알긴산은 포만감을 주고 콜레스테롤 및 중성 지방의 흡수를 억제한다. 또 요오드는 갑상선 호르몬인 티록신의 분비를 촉진하는데 갑상선 호르몬은 인체의 대사기능을 활발하게 하여 체지방의 분해를 촉진시킨다.Alginic acid in kelp and seaweed gives satiety and inhibits the absorption of cholesterol and triglycerides. In addition, iodine promotes the release of thyroid hormone thyroxine, which stimulates the body's metabolism to promote the breakdown of body fat.
두충은 두충과에 속하는 낙엽교목. 학명은 Eucommia ulmoides OLIVER이다. 두충성분을 토끼에게 투여한 결과 혈압하강 효과가 확인된 바 있고, 혈관에 콜레스테롤이 많이 침착되어 일어나는 콜레스테롤성 동맥경화증에도 현저한 효과를 보였다. 다량 복용에서는 진정작용이 나타났고, 진통작용이 있었다. 신장의 기능허약에서 오는 요통에 효과가 있으며, 이에 따라 수반되는 하체의 무력감, 생식기능 감퇴, 소변을 자주 보고 어지러운 증상에 널리 활용된다. 임신 중 유산의 전조증으로 복통과 자궁출혈을 보일 때에 복용하면 유산방지작용이 있다. 고혈압 환자로 허리와 다리가 은근히 아프고 어지러울 때에 다른 약물과 배합하여 사용한다. 민간에서는 잎을 달여서 신경통·고혈압에 쓰고 차로도 복용한다. 한방에서 많이 쓰이고 있으며, 대표적인 처방은 유산에 응용되는 보산탕(保産湯), 요통에 쓰이는 여신산(如神散)이 있다.The larvae are deciduous trees belonging to the larva family. The scientific name is Eucommia ulmoides OLIVER. When the worms were administered to rabbits, the effect of lowering blood pressure was confirmed, and a significant effect on cholesterol arteriosclerosis caused by the deposition of a large amount of cholesterol in blood vessels. In high doses, sedation appeared and pain relief. It is effective for low back pain from kidney weakness, and it is widely used for dizziness due to weakness of the lower body, decreased reproductive function, and frequent urination. Pregnancy of the miscarriage during pregnancy, abdominal pain and uterine bleeding when taken when there is a lactic acid preventive action. If you have high blood pressure and your back and legs are sore and dizzy, use it with other drugs. In the private sector, the leaves are decocted and used for neuralgia and hypertension. It is widely used in oriental medicine, and the typical prescriptions are Bosan-tang (保 産 湯), which is used for lactic acid, and Yeoshin-san (如 神 散), which is used for low back pain.
두충이 갖고 있는 대사촉진 성분과 이뇨 효과 성분, 타닌, 비타민C, 칼슘 등의 상승작용에 의해 인체 기능의 균형을 유지하기 때문에 비만이 방지된다. 중국인들이 기름진 음식을 많이 먹으면서도 비만인 사람이 적은 이유는 바로 식후에 두충차를 복용하는 습관에 있다. Metabolic stimulating ingredients, diuretic effect ingredients, tannins, vitamin C, calcium, etc. have a balance of function of the body, so obesity is prevented. The reason why Chinese people eat a lot of oily foods and few people are obese is that they take a tea after eating.
녹차는 폴리페놀, 아미노산, 비타민, 미네랄, 탄수화물 등의 성분을 가지고 있으며 칼로리가 매우 낮고, 녹차의 카테킨 성분은 체중감소에 도움이 되는 것으로 알려져 있다. 특히 녹차를 마시고 운동하면 지방이 에너지원으로 먼저 사용되므로 효과적으로 지방을 줄일 수 있다. 이러한 지방축적 억제 효과는 카테킨 성분의 콜레스테롤이나 중성 지질의 감소 효과와 함께 나타나므로 훨씬 좋은 다이어트 결과를 가져오는 것으로 알려져 있다. 그 밖에도 항암 효과(녹차의 발암 억제 작용)를 가지며, 고혈압, 동맥경화 예방 콜레스테롤 저하 작용과 해독작용(항암과 세균 발육저지)등이 있다.Green tea contains polyphenols, amino acids, vitamins, minerals, carbohydrates, and low calories. The catechins of green tea are known to help with weight loss. In particular, if you drink green tea and exercise, fat is used first as an energy source, which can effectively reduce fat. This fat accumulation inhibitory effect is known to bring about a much better diet result because the catechin component is shown to reduce cholesterol and neutral lipids. In addition, it has an anti-cancer effect (green tea's carcinogenic effect), hypertension, atherosclerosis prevention cholesterol lowering action and detoxification action (anticancer and bacterial growth inhibition).
녹차에 포함되어 있는 카테킨은 폴리페놀의 일종으로 항산화작용을 가지고 있다.Catechin, which is contained in green tea, is a polyphenol and has antioxidant activity.
백합(百合)은 백합과 다년생 초본인 참나리의 뿌리로서, 여러 종류가 있으나 약으로는 흰 꽃이 피는 종만 사용한다. 그 뿌리는 수많은 비늘줄기가 겹쳐져서 이루어져 있는데, 백합이라는 이름의 유래는 여기서 유래했다고 여겨진다. 백합은 진액을 생성시키고 폐를 윤택하게 하여 오랜 기침, 마른기침을 멈추게 하고 정신을 안정시키며 사고력, 언어, 행동, 미각이 상실되고 입맛이 없고 소변이 붉은 증상에 사용한다. 약리작용으로서는 진해작용, 백혈구감소증유효반응, 강장작용, 항산화작용, 진정작용, 항알레르기작용 등이 알려진바 있다. 식욕은 억제하기 어려운 본능적인 욕구이며 건강한 삶을 위한 정상적인 식생활을 유지 하려면 과다한 식욕을 억제하는 진정작용을 필요로 하게 된다. 세라믹 발효로 효능이 높아진 백합뿌리의 진정작용으로 식욕을 억제 할 수 있으며, 더욱 강력해진 항산화력은 신체건강 균형을 잡고 면역력을 증강하게 되어 무리한 식욕을 요구하지 않게 된다. Lilies (百合) is the root of lily and perennial herbaceous fern, which has many varieties, but uses only white-flowered species as medicine. Its roots consist of numerous layers of scales, and the name lily is believed to originate here. Lilies produce essence and soothe the lungs to stop long-standing coughs and dry coughs, to calm the mind, to lose thought, language, behavior, taste, and to taste for redness. As a pharmacological action, antitussive action, leukopenia effective reaction, tonic action, antioxidant action, sedation action, anti-allergic action and the like are known. Appetite is an instinctive need that is difficult to suppress, and maintaining a normal diet for a healthy life requires sedation that suppresses excessive appetite. The potency of lily root, which is enhanced by ceramic fermentation, can suppress appetite. The more powerful antioxidant power balances the health of the body and enhances immunity, so it does not require excessive appetite.
감잎에는 비타민C 외에도 탄닌, 카로틴, 유기산, 플라보노이드배당체, 당, 정유, 엽록소 등 다양한 성분이 함유되어 있으며 100 g 당 200 mg의 비타민C가 함유되어 있으며 어린 감나무의 잎은 레몬의 20배가량의 비타민C가 함유되어 있다. 감잎은 플라보노이드 배당체인 폴리페놀과 비타민 C의 함량이 높으므로 우수한 항산화작용을 가지고 있다. Persimmon leaves contain various ingredients such as tannin, carotene, organic acids, flavonoid glycosides, sugars, essential oils, and chlorophyll, and 200 mg of vitamin C per 100 g. The leaves of young persimmons are 20 times more vitamins than lemons. C is contained. Persimmon leaves have high antioxidant content because they contain high levels of polyphenols and vitamin C, which are flavonoid glycosides.
우엉은 당질과 칼륨, 마그네슘, 아연 등의 무기질이 높은 알칼리성 식품이며, 당질의 주성분은 당뇨병 환자와 신장이 안 좋은 사람에게 좋은 이눌린(inulin)으로 전체 당질의 50% 이상이다. 그밖에 셀룰로오스(cellulose), 헤미셀룰로오스(hemicellulous) 등의 섬유질이 8.84g으로 당근 3.16g에 비해 많이 함유하고 있어 당뇨병, 변비, 대장암을 예방하고 발암물질이나 중금속을 배설하는 작용을 한다. 특히 우엉에 함유된 알긴은 성호르몬과 신진대사를 촉진 시키며 혈행(血行)을 원활하게 하여 오래된 피를 배출한다. Burdock is an alkaline food with high minerals such as sugar, potassium, magnesium, and zinc. The main component of carbohydrate is inulin, which is good for diabetics and people with poor kidneys. In addition, cellulose, hemicellulous, and other fiber is 8.84g, which contains more than 3.16g of carrots to prevent diabetes, constipation, colon cancer, and excrete carcinogens and heavy metals. In particular, algin in burdock promotes sex hormones and metabolism, and facilitates blood circulation (血 行) to discharge old blood.
본 발명에서 사용되는 용어 “계내금”은 꿩과의 닭(Gallus domesticus Brisson)의 모래주머니의 내막(內膜)을 말한다. 비위가 허약하여 소화가 잘 안되며 식욕이 떨어질 때, 구토, 소화장애, 더부룩함, 복부팽만, 등의 식체에 효과가 있다. 약리 작용으로 위액분비, 위장운동 증가작용, 방사성 원소 배설 촉진 작용, 항암작용 등에 알려져 있다. 조류인 닭의 소화기관 중 위는 포유동물과 달리 소낭, 선위 및 근위로 구성되어 있으며, 평활근으로 구성된 근위는 섭취된 사료와 선위에서 분비된 소화액을 혼합하며 사료를 기계적으로 마쇄하는 작용을 한다. 계내금은 체내에 음식물이 흡수되면 위벽의 신경근을 흥분시켜 위액 분비량을 증가시키므로 소화를 촉진시킬 수 있으며, 포유동물에 비해 치아가 약한 닭의 소화기관인 모래주머니 내에는 강력한 단백질 분해 효소와 유사한 기능의 효소가 있다. 이와 같은 계내금의 천연효소를 이용하여 세라믹발효를 하게 되면 각 성분들이 가지고 있는 효능을 극대화 할 수 있다. As used in the present invention, the term "innervation" refers to the inner lining of a sandbag of a Pheasant chicken (Gallus domesticus Brisson). Difficulty digestion due to weak stomach, poor appetite, vomiting, digestive disorders, bloating, abdominal bloating, and the effect is effective. It is known as a pharmacological action, gastric juice secretion, gastrointestinal motility increase, radioactive element excretion promoting action, anticancer action. Unlike mammals, the stomach of the bird's digestive system is composed of vesicles, the stomach and the proximal muscle, and the proximal muscle composed of smooth muscle mixes the digested fluid secreted from the stomach and serves to mechanically grind the feed. When the food is absorbed into the body, it stimulates the nerve roots of the stomach wall and increases the secretion of gastric juice, which can promote digestion.In the sandbags, which are digestive organs of chickens with weak teeth compared to mammals, they have a similar function as proteolytic enzymes. There is an enzyme. If the fermentation of ceramics using natural enzymes in such a system can maximize the efficacy of each component.
본 발명에 사용되고 있는 원료는 식품과 생약들로 이루어져 있는데, 식품과 생약에 포함되어 있는 생리활성 물질들 특히 비타민과 항산화 물질들은 아미노산과 펩티드(Peptide) 결합을 하고 있기 때문에 물로 추출하거나 분말로 만들어 섭취하더라고 인체 내로 생리활성 성분이 충분이 흡수되지 않는다. 이러한 문제를 해결하기 위하여 발효를 하게 되는데 발효과정에서 펩티드 결합이 얼마만큼 충분히 분해되는가 하는 것이 중요한 문제가 된다. The raw materials used in the present invention are composed of foods and herbal medicines, and bioactive substances, particularly vitamins and antioxidants, included in foods and herbal medicines are extracted with water or powdered ingested because they are combined with amino acids and peptides. Even if the biologically active ingredients are not sufficiently absorbed into the human body. In order to solve this problem, fermentation is carried out. However, how much peptide bond is sufficiently degraded during fermentation is an important problem.
본 발명에 작용하는 효소는 천연물질에서 유래되는 것으로서 현미가 발아되는 과정에 생성되는 효소와 계내금에 포함되어 있는 효소가 협력함으로서 발효의 효율이 높아지게 된다. The enzyme acting on the present invention is derived from a natural substance, and the enzyme produced in the process of germinating brown rice and the enzyme contained in the sedimentary gold cooperate to increase the efficiency of fermentation.
또한 발효용기로서 세라믹용기를 사용함으로서 세라믹 용기에서 원적외선이 방출되게 되고, 원적외선의 작용으로 효소작용이 더욱 활성화되기 때문에 발효의 효능이 극대화 되게 된다. In addition, by using a ceramic container as a fermentation vessel, far infrared rays are released from the ceramic container, and the enzyme action is further activated by the action of far infrared rays, thereby maximizing the efficacy of fermentation.
또한 발효과정에서 여러 가지 효소가 생성되고 활성화됨으로서 인체의 대사기능을 비롯하여 여러 가지 기능을 활성화시키는 효과를 가지게 된다. In addition, various enzymes are produced and activated during the fermentation process, which has the effect of activating various functions including the metabolic function of the human body.
본 발명의 구성은 여러 가지 성분의 복합적인 조성으로 포만감을 주고 식욕을 억제하며, 지방대사를 촉진하여 체지방을 감소시켜주며, 항산화작용으로 인체의 독소를 중화시켜주고, 인체기능을 위한 여러 가지 효소를 활성화 시키며, 인체의 필요한 비타민과 미네랄 식이섬유 등을 풍부하게 제공하여 효과적이고 건강한 다이어트를 수행할 수 있게 해주며, 다이어트로 인한 변비 탈모 피부노화 등의 문제점을 방지해 주는 효과를 나타내게 된다.The composition of the present invention is a complex composition of a variety of ingredients to give a feeling of satiety, suppress appetite, promote fat metabolism, reduce body fat, neutralize the toxins of the human body by antioxidant activity, various enzymes for human function It activates, provides abundant vitamins and minerals, such as dietary fiber of the human body to enable an effective and healthy diet, and prevents problems such as constipation and hair loss skin aging caused by the diet.
본 발명의 바람직한 구현 예에 따르면, 볶은콩가루, 볶은보리가루, 발아현미가루, 레시틴, 엘아르기닌, 염산피리독신, 리보플라빈, 니코틴산아미드, 폴리덱스트로즈, 솔비톨, 전분, 바닐라향 첨가제 및 과일향 첨가제로 이루어진 군으로부터 선택된 어느 하나 이상을 추가로 포함할 수 있다. According to a preferred embodiment of the present invention, roasted soybean flour, roasted barley flour, germinated brown rice flour, lecithin, elarginine, pyridoxine hydrochloride, riboflavin, nicotinic acid amide, polydextrose, sorbitol, starch, vanilla flavor additive and fruit flavor additive It may further comprise any one or more selected from the group consisting of.
폴리 덱스트로즈는 수용성식이섬유질로서, 글루코즈, 솔비톨 및 구연산을 가열 중합하여 만든 백색에서 담황색의 비결정성의 분말로 무취, 약간의 산미를 갖는다. Pfizer 회사의 제품으로 1981년 미국에서 식품첨가물로 인정되어 우리나라에서도 식품으로 수입이 인정되었다. 물에 잘 녹아 인간의 소화효소계에서 분해되지 않기 때문에 가용성 식이섬유로서 청량음료수 등에 쓰이고 있다. Polydextrose is a water-soluble dietary fiber, white to pale yellow amorphous powder made by heat polymerization of glucose, sorbitol and citric acid, odorless and slightly acidic. As a product of Pfizer company, it was recognized as a food additive in the US in 1981 and imported as food in Korea. It is soluble dietary fiber and is used for soft drink water because it dissolves well in water and does not decompose in human digestive system.
솔비톨은 백색의 분말로 청량한 단맛이 있으며, 일반적으로 약 70%의 수용액으로서 시판되고 있다. 솔비톨은 분자량이 182.18이며 포도당을 고압첨가, 환원시켜 얻어진다. 6개의 수산기(-OH)를 가진 당알코올로서 D-sorbitol 또는 D-glucitol이라고도 불리어지는데, 자연계에 광범위하게 존재하며 특히 과실류(1~2%), 해조류(13%)에 다량 함유되어 있다. 또한 타첨가물보다 흡습속도가 느려 제품에 대해 비교적 수분의 흡수와 발산에 큰 영향을 주지 않아 제품의 신선도와 유연성을 유지하고, 건조, 균열, 중량손실을 방지하여 품질 및 저장성을 향상시켜 주며, 그외 단백질 변성방지 효과(protein protection effect), 킬레이트 효과(chelate effect), 효소와 곰팡이의 성장에 대한 세균발육 저지력을 가지고 있어 세균발육 저지력은 다른 분야의 용도에 사용되고 있다.Sorbitol is a white powder with a refreshing sweet taste and is generally marketed as an aqueous solution of about 70%. Sorbitol has a molecular weight of 182.18 and is obtained by high pressure addition and reduction of glucose. Sugar alcohols with six hydroxyl groups (-OH), also called D-sorbitol or D-glucitol, are widely found in nature and are found in large quantities in fruits (1-2%) and seaweeds (13%). In addition, the moisture absorption rate is slower than other additives, so it does not significantly affect the absorption and dissipation of water, so it maintains the freshness and flexibility of the product, prevents drying, cracking, and weight loss, and improves quality and storage. As it has protein protection effect, chelate effect, and bacteriostatic activity against the growth of enzymes and fungi, bacteriostatic activity is used in other fields.
레시틴 엘-아르기닌 니코틴산아미드, 염산피리독신(비타민B6), 리보플라빈(B2) 등은 인체의 기능유지에 필요한 영양물질이며, 영양을 강화하고 인체의 대사를 활성화시키고 지방의 축적을 억제하는 작용을 가지고 있다. Lecithin L-arginine nicotinic acid amide, pyridoxine hydrochloride (vitamin B6), and riboflavin (B2) are nutrients necessary to maintain the function of the human body, and have the function of strengthening nutrition, activating the metabolism of the body and inhibiting the accumulation of fat. .
특히 레시틴은 콜레스테롤을 낮춰주고 지방의 축적을 억제하며, 엘-카르니틴은 성장호르몬의 방출을 촉진하고 근육을 보존하고 체지방을 감소시켜준다. 또 염산피리독신(비타민B6), 리보플라빈(B2)은 인체의 대사작용에 필요한 비타민이며 니코틴산 아미드는 혈액순환을 촉진하는 작용을 가지고 있다. In particular, lecithin lowers cholesterol and inhibits fat accumulation, and L-carnitine promotes the release of growth hormone, preserves muscle and reduces body fat. In addition, pyridoxine hydrochloride (vitamin B6) and riboflavin (B2) are vitamins necessary for metabolism of the human body, and nicotinic acid amide has a function of promoting blood circulation.
본 발명의 다른 양태에 따르면, 다음의 단계를 포함하는 식품조성물의 제조방법을 제공한다:According to another aspect of the present invention, there is provided a method of preparing a food composition comprising the following steps:
발아현미, 발아콩, 미역, 백합 및 감잎을 세척하고 건조기에서 70 내지 90 ℃ 보다 바람직하게는 75 내지 85 ℃에서 건조하는 세척 및 건조단계;Washing and drying step of washing germinated brown rice, germinated soybean, seaweed, lily and persimmon leaf and drying at 70-90 ° C., more preferably 75-85 ° C., in a drier;
원료를 분쇄기에 투여하여 분말 형태로 분쇄하는 단계; 및Administering the raw material to a grinder to grind it into a powder form; And
분말 형태로 분쇄된 원료에 정제수를 투여하여 반죽하고 발효하는 단계.The step of kneading and fermentation by administering purified water to the raw material ground in powder form.
본 발명의 바람직한 구현 예에 따르면, 본 발명의 방법은 발효된 원재료를 건조기에서 건조하는 단계; 전분 분말을 첨가하여 반죽하는 단계 및 장환기에서 환의 형태로 제조하는 단계를 추가로 포함할 수 있다. 상기 전분 분말을 첨가하여 반죽하는 단계에서는 볶은콩가루, 볶은보리가루, 발아현미가루, 레시틴, 엘아르기닌, 염산피리독신, 리보플라빈, 니코틴산아미드, 폴리덱스트로즈, 솔비톨, 전분, 바닐라향 첨가제 및 과일향 첨가제로 이루어진 군으로부터 선택된 어느 하나 이상을 추가로 배합하여 실시할 수 있다.According to a preferred embodiment of the present invention, the method of the present invention comprises the steps of drying the fermented raw material in a dryer; It may further comprise the step of kneading by adding the starch powder and preparing in the form of a ring in the long ring machine. In the step of kneading by adding the starch powder, roasted soy flour, roasted barley flour, germinated brown rice flour, lecithin, el arginine, pyridoxine hydrochloride, riboflavin, nicotinic acid amide, polydextrose, sorbitol, starch, vanilla flavor additive and fruit flavor additive Any one or more selected from the group consisting of may be further blended and carried out.
본 발명의 바람직한 구현예에 따르면, 본 발명의 방법은 환제로 형성된 원료를 건조기에서 70℃ 내지 90℃ 보다 바람직하게는 75 내지 85℃의 조건에서 수분함량 15% 미만으로 건조하는 단계 및 UV 살균기로 살균하는 단계를 추가로 포함한다.
According to a preferred embodiment of the present invention, the method of the present invention comprises the steps of drying the raw material formed of pills to less than 15% moisture content in a condition of 70 to 90 ℃ more preferably 75 to 85 ℃ in a dryer and UV sterilizer Further comprises sterilizing.
본 발명은 발아현미, 발아콩, 미역, 백합 및 감잎을 유효성분으로 포함하는 식품조성물에 관한 것이다.The present invention relates to a food composition comprising germinated brown rice, germinated soybean, seaweed, lily and persimmon leaf as active ingredients.
본 발명을 이용하면 하기와 같은 효과가 있다.Use of the present invention has the following effects.
(a) 식사를 하기 어려운 경우 간편하게 섭취할 수 있어 식사 대용으로 이용할 수 있다.(a) If it is difficult to eat, it can be easily consumed and used as a meal substitute.
(b) 저칼로리를 섭취하면서도 포만감을 주며, 그 밖에 식욕억제 성분 및 지방분해성분이 함유되어 있으므로 다이어트에 매우 유용하다.(b) low calorie intake while giving a feeling of satiety, and also contains appetite suppression and lipolysis component is very useful in diet.
(c) 식사만으로 섭취하기 어려운 영양소를 체내에 공급할 수 있으며, 특히 체중 감량시 쉽게 발생할 수 있는 영양의 불균형 현상을 방지할 수 있다.(c) It is possible to supply the body with nutrients that are difficult to eat only by meals, and especially to prevent the nutritional imbalance that can easily occur when losing weight.
(d) 식품원료 및 식품조성에 사용할 수 있는 생약과 영양물질의 조성으로 되어 있으므로 오래 복용하더라도 부작용의 염려 없이 안전하게 사용할 수 있다.
(d) It is composed of herbal medicines and nutrients that can be used for food ingredients and food preparation, so it can be safely used even if taken for a long time without concern of side effects.
실시예Example 1 - 포만감을 증가시키는 체중조절용 건강식품 조성물의 제조 1-Preparation of health food composition for weight control to increase satiety
세척 및 건조Washing and drying
원료를 수돗물에 세척하고 원료를 건조기에 넣어 75~80도C 온도로 건조한다. Wash the raw material in tap water and place the raw material in the dryer to dry at 75 ~ 80 ° C.
분 쇄 Crushing
건조된 원료는 1차 분쇄기 추말망에 넣어 잘게 분쇄하고, 잘게 분쇄된 원료를 2차~3차 분쇄기에 넣어 곱게 갈아 분말로 만든다. 단, 기존 분말로 입고된 재료는 분쇄 및 분말로 만드는 과정을 생략한다.The dried raw material is pulverized in a first grinder poultry network, finely pulverized raw materials are put in a second to third grinder finely ground to a powder. However, the material put into the existing powder is omitted the grinding and powdering process.
발 효 Fermentation
표 1의 No. 1 내지 No. 12의 재료를 표에 나타난 배합비율로 재료를 배합하고 재료에 정제수를 넣어 잘 섞어 반죽상태에서 발효한다. No. of Table 1 1 to No. The ingredients of 12 are mixed in the mixing ratios shown in the table, and purified water is added to the ingredients and mixed well.
건 조 및 반죽Dried and Dough
발효된 원재료를 건조기에 넣어 장환 될 수 있도록 적당히 건조시킨 후발효, 건조된 원료에 No. 13 내지 21번 원료를 배합하여 반죽한다. 제환 점도를 맞추기 위하여 전분 분말로 만든 풀을 이용한다.After fermented raw materials are put into a dryer and dried appropriately, no fermentation and dried raw materials can be used. Knead 13-21 ingredients. A paste made of starch powder is used to match the viscosity of the refill.
제 환 Reclaim
잘 반죽된 원료를 장환기 크기에 맞추어 내고 장환기에서 일정한 크기로 장환한 후 장환된 원료를 제환기에서 환으로 제조한다. 제환된 반제품은 당의기에서 1차 건조하면서 원모양으로 형성한다. The well-kneaded raw material is cut out according to the size of the filling machine, and it is loaded in a constant size in the filling machine, and then the loaded raw material is manufactured into the ring in the feeding machine. The returned semi-finished product is formed in a circular shape with primary drying in a dragee.
건조 및 살균 Drying and sterilization
환제로 형성된 원료를 건조기에서 85 ℃ 이상의 온도조건에서 수분함량Moisture content of raw materials formed by pills in the temperature condition above 85 ℃
15% 미만으로 건조시키고 건조기내 UV 살균기로 살균한다.
Dry to less than 15% and sterilize with a UV sterilizer in the dryer.
실시예Example 2 - 식욕억제, 체지방분해 및 포만감 성능실험 2-Appetite suppression, body fat breakdown and satiety performance test
20대 및 30대; 40대; 50대를 각각 7명씩 3개 군으로 나누어 총 21명의 본인이 비만하다고 여기는 여성을 대상으로 15일간 본 발명의 식품조성물을 복용하도록 하여 그 성능을 실험하였다.Twenties and thirties; 40's; A total of 21 women in their 50s were divided into three groups of seven people, and a total of 21 women were considered obese to take the food composition of the present invention for 15 days.
실험기간 중 실험 대상자는 저녁식사로 본 제품을 대용 하게 하였으며 15일 후 감량된 체중과 식사를 대용한 총 횟수를 조사 하였다.During the experiment, subjects were asked to substitute the product for dinner, and after 15 days, the weight loss and the total number of meals were substituted.
실험결과, 연령대별로 높은 연령대의 감량 효과가 높았으며 평균 4.3kg의 체중 감량 효과를 보였다.As a result, the weight loss effect of high age group was high and average weight loss effect was 4.3 kg.
식욕억제와 포만감에 관련하여 본 발명품을 복용한 21명의 15일 중 한 끼인 누계 315회 식사 중(21명*15일 한끼=315회)86%가 식욕억제와 포만감으로 인하여 본 제품을 대용으로 식사를 거를 수 있었다.
86% of the total 315 meals (21 people * 15 meals = 315 meals) out of 21 people who took the present invention with regard to appetite suppression and satiety (21 people * 15 meals = 315 times) Could filter.
감량 무게
Weight loss
Claims (8)
Food composition containing germinated brown rice, germinated soybean, seaweed, lily and persimmon leaf as active ingredients.
The composition of claim 1, further comprising kelp, tofu, green tea, burdock, and sesame seed.
The composition of claim 1, wherein the germinated brown rice, germinated soybean, seaweed, lily and persimmon leaf are fermented.
The method of claim 1, wherein the roasted soy flour, roasted barley flour, germinated brown rice flour, lecithin, elarginine, pyridoxine, riboflavin, nicotinic acid amide, polydextrose, sorbitol, starch, vanilla flavor additive, and fruit flavor additive The composition further comprises any one or more selected.
The composition of claim 1 wherein the composition has a powder or pill formulation.
발아현미, 발아콩, 미역, 백합 및 감잎을 세척하고 건조기에서 70 내지 90 ℃에서 건조하는 세척 및 건조단계;
원료를 분쇄기에 투여하여 분말 형태로 분쇄하는 단계; 및
분말 형태로 분쇄된 원료에 정제수를 투여하여 반죽하고 발효하는 단계.
Process for preparing a food composition comprising the following steps:
Washing and drying step of washing germinated brown rice, germinated soybean, seaweed, lily and persimmon leaf and drying at 70-90 ° C. in a dryer;
Administering the raw material to a grinder to grind it into a powder form; And
The step of kneading and fermentation by administering purified water to the raw material ground in powder form.
발효된 원재료를 건조기에서 건조하는 단계; 전분 분말을 첨가하여 반죽하는 단계 및 장환기에서 환의 형태로 제조하는 단계를 추가로 포함하는 것을 특징으로 하는 방법.
The method according to claim 6,
Drying the fermented raw materials in a dryer; Adding starch powder to kneading and preparing in the form of a ring in a long ring machine.
8. The method according to claim 7, further comprising the step of drying the raw material formed of the pill in a drier at less than 15% of water content in the conditions of 70 ℃ to 90 ℃ and sterilization with a UV sterilizer.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020110093557A KR20130030049A (en) | 2011-09-16 | 2011-09-16 | The health food composition for regulating weight and increasing the satiety |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020110093557A KR20130030049A (en) | 2011-09-16 | 2011-09-16 | The health food composition for regulating weight and increasing the satiety |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20130030049A true KR20130030049A (en) | 2013-03-26 |
Family
ID=48179763
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020110093557A KR20130030049A (en) | 2011-09-16 | 2011-09-16 | The health food composition for regulating weight and increasing the satiety |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20130030049A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20190016755A (en) | 2017-08-09 | 2019-02-19 | (주)케이피내츄럴 | Diet-food composition for inducing satiation comprising L-tryptophan and dietary fiber of chicory and method for preparing diet tablet using the same |
-
2011
- 2011-09-16 KR KR1020110093557A patent/KR20130030049A/en not_active Application Discontinuation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20190016755A (en) | 2017-08-09 | 2019-02-19 | (주)케이피내츄럴 | Diet-food composition for inducing satiation comprising L-tryptophan and dietary fiber of chicory and method for preparing diet tablet using the same |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107173694A (en) | A kind of full vegetarian diet meal replacement powder formula of comprehensive nutrition balance | |
CN110447902B (en) | Composition with weight-losing effect | |
KR101611954B1 (en) | A process for the preparation of fermented minerals pills for improving intestine function and fermented minerals pills prepared therefrom | |
KR20020077581A (en) | Processing Methods of Health Food for the Control of Body Weight | |
KR101883154B1 (en) | Method of manufacturing a fermented food that can help diabetes using the Hordeum vulgare L. and fermented food that has been produced by it | |
KR20140038101A (en) | Kimchi for improvement of skin and manufacturing method thereof | |
KR101632794B1 (en) | METHOD OF MANUFACTURING PILL COMPRISED OF Protaetia brevitarsis seulensis | |
CN101147527B (en) | Feed capable of leading duck egg to have softening blood vessel and reducing blood pressure function and preparation method | |
KR101642176B1 (en) | Composition for enhancing growth and reinforcing immunity | |
CN112544767A (en) | Preparation method of selenium-rich tabletted candy | |
KR20050047053A (en) | Meal substitutes based on brown rice and various nutritional ingredients | |
KR101186508B1 (en) | Manufacturing method of healthy food using germinated grain | |
KR102376726B1 (en) | Health functional pet food using deer meat and manufacturing method thereof | |
KR20170086198A (en) | Manufacturing method of diet solid tea including fermentation herb remedy and dietary fiber and the solid tea produced thereby | |
CN109452417A (en) | A kind of pure natural fat eliminating Weight reducing tea drink and preparation method thereof | |
KR101687558B1 (en) | A composition containing natural materials extract as an active ingredient for treatment of constipation, and manufacturing method of the same | |
KR100503208B1 (en) | Diet-food composition | |
KR20190118720A (en) | Functional and eco-friendly adjuvants for pig feeds based on black tea mugwort, and its production method, pig breeding method and the pork making thereof | |
KR102418319B1 (en) | Stew composition for pet and method of manufacturing the same | |
KR100994071B1 (en) | The healthful foods | |
KR102082115B1 (en) | Manufacturing method of healthy foods using protaetia brevitarsis | |
KR20130030049A (en) | The health food composition for regulating weight and increasing the satiety | |
KR101079643B1 (en) | Composition of food for augmenting kidney function and preparation method thereof | |
KR20050080501A (en) | A making method of health assistance food for high blood pressure, fatness, diabetes patients. | |
KR101690415B1 (en) | Health food using chlorophyll, embryo bud of rice, gastrodia elata, chia seed |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application |